Palladin (PALLD) Antibody
780€ (1 ml)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
Palladin (PALLD) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx173941
tested applications
WB, IHC, IF/ICC
Description
This product is currently in development. The lead time for this product may be several months. Please contact us at
Documents del producto
Instrucciones
Data sheet
Product specifications
| Category | Primary Antibodies |
| Immunogen Target | Palladin (PALLD) |
| Host | Mouse |
| Reactivity | Human |
| Recommended Dilution | WB: 0.01-2 µg/ml, IHC: 5-20 µg/ml, IF/ICC: 5-20 µg/ml. Optimal dilutions/concentrations should be determined by the end user. |
| Clonality | Monoclonal |
| Conjugation | Unconjugated |
| Purification | Purified by Protein A and Protein G affinity chromatography. |
| Size 1 | 1 ml |
| Form | Liquid |
| Tested Applications | WB, IHC, IF/ICC |
| Buffer | 0.01 M PBS, pH 7.4, containing 0.05% Proclin-300, 50% glycerol. |
| Availability | Please enquire. |
| Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
| Dry Ice | No |
| Alias | MYN,PNCA1,CGI151,SIH002,CGI-151,SIH002,Sarcoma antigen NY-SAR-81 |
| Background | Antibody anti-PALLD |
| Status | RUO |
Descripción
Palladin, cytoskeletal associated protein (PALLD) is a pivotal component of the cytoskeleton, playing a vital role in the organization, dynamics, and stability of actin filament networks within the cell. It acts as a scaffolding protein that binds directly to actin and other actin-associated proteins, thus facilitating the formation of stress fibers, lamellipodia, and other cellular structures critical for migration and adhesion. Palladin is especially active during developmental processes, tissue repair, and cancer metastasis, where enhanced cellular motility and structural remodeling are required. Mutations or dysregulation of PALLD have been linked to diseases such as cancer progression and certain connective tissue disorders, making it a key focus of cellular and molecular biology research.
